FDA Okays Orsiro, First Ultrathin Drug-Eluting Coronary Stent FDA Okays Orsiro, First Ultrathin Drug-Eluting Coronary Stent

The ultra-thin biodegradable polymer stent has been available since 2011 in Europe.FDA Approvals

Source: Medscape Medical News Headlines - February 22, 2019 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news